South Rampart Pharma, Inc.

A Two-Part randomized, Double-Blind, Placebo-Controlled study to assess the safety, tolerability and pharmacokinetics of single ascending and multiple ascending oral doses of SRP-3D (DA), and to characterize the effect of food on the pharmacokinetics of SRP-3D (DA), in healthy male and female subjects

Phase 1 • Sponsor: South Rampart Pharma, Inc.

Last updated Sep 10, 2026 17:00 UTC